ReviewCancer cell international2019
CRISPR-Cas9 a boon or bane: the bumpy road ahead to cancer therapeutics.
Debarati Ghosh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ReviewCancer cell international2019
Debarati Ghosh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.